Lamictal Buyers Ask High Court Not To Take Antitrust Case
Buyers of the anticonvulsant drug Lamictal urged the U.S. Supreme Court on Monday to turn away GlaxoSmithKline and Teva's appeal in a pay-for-delay case, arguing lower courts rightly held that an...To view the full article, register now.
Already a subscriber? Click here to view full article